Vedanta News: Anil Agarwal's company gave a gift of 2737 crores to those who bought the shares, money will be available till this day

News Topical, Digital Desk : Anil Agarwal's company Vedanta Limited has given good news to its investors. The company's board has approved the first interim dividend of Rs 7 per equity share with a face value of Rs 1 for the financial year 2025-26. The company's total dividend on this dividend is Rs 2,737 crore. The dividend will be paid on the basis of the record date on June 24, 2025 and it will be completed within the legal deadline.

The company had already informed that it would consider the dividend proposal in the board meeting today i.e. on June 18. The record date for this was also fixed.

Stake sale in Hindustan Zinc
Apart from this, the company has given another information. Vedanta has sold 66.7 million shares (1.6% equity) in its subsidiary Hindustan Zinc Limited to institutional investors for Rs 3,028 crore. This sale was done through the bookbuild process. The company said that this capital will be used to strengthen the balance sheet and increase financial flexibility. This move is part of Vedanta's demerger plan, under which the company will be divided into separate units in different regions. This transaction reflects the confidence of investors, who are excited by the company's record production, cost efficiency and long-term value creation strategy. Vedanta's dividend history Vedanta gave a dividend of Rs 17,000 crore to its shareholders in the financial year 2025, which was Rs 43.5 per share. In the last four years, the company has distributed dividends of more than Rs 200 per share to its shareholders.

Brokerage opinion
Global brokerage firm JPMorgan said in its note on May 1 that Vedanta's dividend in the financial year 2026 may be halved compared to 2025 and may be Rs 25 per share. In the financial year 2027, it is expected to be Rs 27 per share. On Tuesday, Vedanta shares closed 0.6% higher at Rs 461. So far in 2025, the stock has seen a growth of 3%.

Read More: Stock Market News: Company receives Warning Letter from US FDA, shares fall